<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(4)</volume><submitter>Radom M</submitter><pubmed_abstract>Radioiodine (RAI) therapy, used for treating differentiated thyroid cancers (DTCs), hinges on the functional expression of the sodium-iodide symporter (NIS). However, up to 60% of papillary thyroid carcinomas, the most common DTC subtype, harbor BRAF&lt;sup>V600E&lt;/sup> mutations, which are strongly associated with reduced NIS expression, impaired RAI uptake, and poor differentiation scores. For patients with RAI-refractory, a promising therapeutic strategy is to restore RAI sensitivity by inducing tumor redifferentiation. Here, we demonstrate that NOX4-derived reactive oxygen species (ROS) contribute to NIS repression in BRAF&lt;sup>V600E&lt;/sup>-mutated thyroid cancer cells. Particularly, NOX4-generated oxidative DNA damage recruits DNA repair proteins, including OGG1 and MSH2/MSH6 proteins, whic</pubmed_abstract><journal>International journal of biological sciences</journal><pagination>1674-1692</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12905579</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>NOX4-derived oxidative DNA damage impairs thyroid differentiation through an epigenetic mechanism in BRAF-mutated radioactive iodine refractory papillary thyroid cancer cells.</pubmed_title><pmcid>PMC12905579</pmcid><pubmed_authors>Harinquet M</pubmed_authors><pubmed_authors>Buffet C</pubmed_authors><pubmed_authors>Bani MA</pubmed_authors><pubmed_authors>Droin N</pubmed_authors><pubmed_authors>Dayris T</pubmed_authors><pubmed_authors>Cazarin J</pubmed_authors><pubmed_authors>Ghuzlan AA</pubmed_authors><pubmed_authors>Braye F</pubmed_authors><pubmed_authors>Aglave M</pubmed_authors><pubmed_authors>Leboulleux S</pubmed_authors><pubmed_authors>Mesloub Y</pubmed_authors><pubmed_authors>Godefroy K</pubmed_authors><pubmed_authors>Dupuy C</pubmed_authors><pubmed_authors>de Faria CC</pubmed_authors><pubmed_authors>Radom M</pubmed_authors><pubmed_authors>Lamartina L</pubmed_authors><pubmed_authors>Nobre C</pubmed_authors></additional><is_claimable>false</is_claimable><name>NOX4-derived oxidative DNA damage impairs thyroid differentiation through an epigenetic mechanism in BRAF-mutated radioactive iodine refractory papillary thyroid cancer cells.</name><description>Radioiodine (RAI) therapy, used for treating differentiated thyroid cancers (DTCs), hinges on the functional expression of the sodium-iodide symporter (NIS). However, up to 60% of papillary thyroid carcinomas, the most common DTC subtype, harbor BRAF&lt;sup>V600E&lt;/sup> mutations, which are strongly associated with reduced NIS expression, impaired RAI uptake, and poor differentiation scores. For patients with RAI-refractory, a promising therapeutic strategy is to restore RAI sensitivity by inducing tumor redifferentiation. Here, we demonstrate that NOX4-derived reactive oxygen species (ROS) contribute to NIS repression in BRAF&lt;sup>V600E&lt;/sup>-mutated thyroid cancer cells. Particularly, NOX4-generated oxidative DNA damage recruits DNA repair proteins, including OGG1 and MSH2/MSH6 proteins, whic</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026</publication><modification>2026-07-15T16:32:03.852Z</modification><creation>2026-07-07T03:08:37.172Z</creation></dates><accession>S-EPMC12905579</accession><cross_references><pubmed>41694580</pubmed><doi>10.7150/ijbs.123980</doi></cross_references></HashMap>